Sep 2026· Journal of Visualized Experiments· Vol 235· 0 citations
Medicine
TL;DR
An association between FLVCR1-related heme metabolism and immune alterations in keloid pathogenesis is suggested and metabolic-immune intervention as a novel therapeutic strategy is proposed.
Abstract
Keloid is a fibroproliferative disorder with high recurrence and unclear pathogenesis, lacking effective therapeutic targets. Recent evidence suggests metabolic reprogramming, particularly in heme metabolism, may drive fibrosis. This study investigates the role of heme metabolism, focusing on feline leukemia virus subgroup C receptor 1 (FLVCR1), in keloid pathogenesis and explores its diagnostic and therapeutic potential. We analyzed bulk RNA-seq datasets and single-cell RNA-seq data (scRNA-seq). Differential expression, least absolute shrinkage and selection operator (LASSO), and random forest (RF) models identified heme metabolism-related diagnostic biomarkers. Immune infiltration, single-cell mapping, microRNA (miRNA) network construction, and molecular docking with traditional Chinese medicine compounds were performed. Six heme metabolism-related biomarkers were identified, forming a diagnostic nomogram with high accuracy. FLVCR1, enriched in endothelial cells and melanocytes, correlated negatively with T follicular helper cells, suggesting immunometabolic crosstalk. MiRNA regulatory network analysis revealed five miRNAs co-targeting all six biomarkers. Molecular docking identified (+)-gallocatechin as a high-affinity FLVCR1 ligand. These findings suggest an association between FLVCR1-related heme metabolism and immune alterations in keloid pathogenesis. The biomarker panel showed exploratory diagnostic potential, and (+)-gallocatechin was identified as a candidate FLVCR1-interacting compound requiring further validation. This study reframes keloid within the metabo-fibrotic spectrum and proposes metabolic-immune intervention as a novel therapeutic strategy.
The important role of macrophage-associated nucleotide metabolism in HTS is revealed and NCF1 and GPR34 are identified as potential biomarkers and therapeutic targets.
Qiyun Luo, Xia Yang, Jiang-Yong Shen et al.· Journal of Burn Care & Resea...· 0 citations
Findings establish LIPA as a critical link between lipid metabolism, ferroptosis, and immune modulation in LUAD, and provide a prognostic signature for risk stratification as well as a candidate compound for targeting lipid metabolic vulnerabilities.
Fan Zhang, Shuai Han, Xiao-Dong Cao et al.· Molecular and Cellular Bioch...· 0 citations
A psoriasis-specific metabolic-immune imbalance network with CD36, IL1B, and CREB1 as the core is outlined and Multidimensional validation supports their potential for patient stratification and targeted treatment and provides a basis for future drug development.
Hui-Huang He, Xue-Song Xiang, Yan-Fang Zhang et al.· Journal of the College of Ph...· 0 citations
This study identified four novel mitochondrial homeostasis-associated hub genes involved in NPC metastasis, established a mitochondria-based molecular subtyping scheme, and provided preliminary prognostic biomarkers and potential therapeutic targets for future mechanistic and translational investigations of metastatic...
Background The development and progression of colorectal cancer (CRC) are closely associated with metabolic reprogramming, in which mitochondrial metabolism is critically associated with tumor cell survival and proliferation. This study aims to provide novel insights for mitochondrial metabolism-related genes (MMRGs)-b...
Xin-Yu Li, Kai Zhang, Tao-Tao Liu et al.· Translational Gastroenterolo...· 0 citations
C17-sphinganine is a core metabolic biomarker for distinguishing kidney-liver deficiency syndrome from heat-dampness syndrome, enabling precise syndrome classification with a single measurement.
Yao Li, Ying Wu, Jin-Xiang Zeng et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.